Phase II - base year
Ended Definitive Contract Awarded Last action
- Contract number
- W911SR23C0019
- Awardee
-
CMC Pharmaceuticals, Inc. UEI R9AVS7XL2YB4
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $1,094,181
Award facts
- Contract value 100% obligated
- $1,094,180.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Solon, OH 44139, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $431,622 | |
| Original award | $662,559 |
About this award
This is a $1,094,180.64 firm-fixed-price definitive contract awarded by the U.S. Department of Defense's Joint Program Executive Office for Chemical and Biological Defense to CMC Pharmaceuticals, Inc., a woman-owned small business, for Phase II of a Small Business Innovation Research (SBIR) program. The contract is for the research, development, testing, and manufacturing of pharmaceutical products such as atropine sulfate formulations and scopolamine hydrobromide vials. This award is a follow-on to previous SBIR Phase I and other R&D contracts CMC Pharmaceuticals has performed for the DoD and U.S. Special Operations Command, demonstrating the company's expertise in traditional formulations and innovative drug delivery systems. The contract has a completion date of July 2, 2025 and is set aside for total small businesses.
Quick answers
Who was awarded contract W911SR23C0019?
W911SR23C0019 was awarded to CMC Pharmaceuticals, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on June 27, 2023.
How much is contract W911SR23C0019 worth?
The government has obligated $1,094,181 on W911SR23C0019.
Which agency awarded contract W911SR23C0019?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR23C0019, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911SR23C0019 competed?
The extent of competition for W911SR23C0019 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award